Reported July 19, Select Medical Announces Preliminary Financial Results For Q2 In connection With Refinancing Discussions; Sees Q2 EPS $0.61 Vs $0.48 Est; Revenue $1.67B Vs $1.64B Est; $100M Of Cash And $3.75B Of Indebtedness On Its Balance Sheet
Portfolio Pulse from Happy Mohamed
Select Medical Holdings Corporation (NYSE:SEM) has announced preliminary financial results for Q2 2023, ahead of its actual results announcement on August 3, 2023. The company expects Q2 EPS of $0.61, beating the estimated $0.48, and revenue of $1.67B, slightly above the estimated $1.64B. The company also reported $100M of cash and $3.75B of indebtedness on its balance sheet. The company is currently in discussions with lenders regarding refinancing of its outstanding debt.
July 20, 2023 | 3:02 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Select Medical's preliminary Q2 2023 results beat estimates, which could positively impact its stock. However, the company's high indebtedness and ongoing refinancing discussions could introduce uncertainty.
Beating earnings estimates typically boosts a company's stock. However, high indebtedness and ongoing refinancing discussions could introduce uncertainty, potentially offsetting the positive impact of the earnings beat.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100